pharmacopeia
GET
/api/v1/drug/zinc-gluconate

Mechanism of action

Sourced from openFDA

Mechanism-of-action classes: Acid-Base Activity; Electrolyte Activity; Enzyme Interactions.

Indications

Sourced from openFDA
  • Uses reduces the duration of the common cold reduces the severity of cold symptoms: cough, sore throat, nasal congestion, post nasal drip and/or hoarsenessICD-10: J00, R05.9

Dosage & administration

Sourced from openFDA

Directions • take one lozenge at the onset of symptoms • dissolve entire lozenge in mouth • do not chew • do not swallow whole • do not eat or drink for 15 minutes after use • repeat every 2-4 hours until symptoms subside Adults 18 years and over do not exceed 6 lozenges per day Children 12 to under 18 years do not exceed 4 lozenges per day Children under 12 years ask a doctor before use

Warnings & precautions

Sourced from openFDA

Do not use for treatment of influenza or allergies. This product is intended only to reduce the duration of the common cold and its symptoms. Ask a doctor or pharmacist before use if you are taking minocycline, doxycycline, tetracycline or are on Coumadin (warfarin) therapy. Zinc treatment may inhibit the absorption of these medicines. When using this product do not take on an empty stomach (to avoid possible minor stomach upset) Stop use and ask your doctor if symptoms persist more than 7 days If pregnant or breastfeeding , ask a healthcare professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
25,807 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Fatigue2,70410%
  2. 2Pain1,9587.6%
  3. 3Nausea1,9307.5%
  4. 4Diarrhoea1,9297.5%
  5. 5Headache1,8507.2%
  6. 6Off Label Use1,8287.1%
  7. 7Drug Ineffective1,5566.0%
  8. 8Dyspnoea1,4935.8%
  9. 9Arthralgia1,3485.2%
  10. 10Dizziness1,3415.2%
  11. 11Asthenia1,2764.9%
  12. 12Fall1,2654.9%
  13. 13Constipation1,1254.4%
  14. 14Rash1,0944.2%
  15. 15Vomiting1,0103.9%

Literature

View JSON

Recent PubMed references pinned to Zinc Gluconate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 71 ClinicalTrials.gov registrations naming Zinc Gluconate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Zinc Gluconate work?
Mechanism-of-action classes: Acid-Base Activity; Electrolyte Activity; Enzyme Interactions.
What is Zinc Gluconate used for?
According to FDA labeling, Zinc Gluconate carries indications including: Uses reduces the duration of the common cold reduces the severity of cold symptoms: cough, sore throat, nasal congestion, post nasal drip and/or hoarseness. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Zinc Gluconate?
Zinc Gluconate is classified as Zinc, Acid-Base Activity, Electrolyte Activity, Enzyme Interactions.
Note. Data for zinc-gluconate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients